Is Balaxi Pharmaceuticals Ltd (BALAXI) Halal and Shariah Compliant?
Current Price
Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines. The company operates in the healthcare sector, which is generally considered permissible
- Stock is trading at 0.52 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 3.15% over past five years.
- Company has a low return on equity of -3.58% over last 3 years.
Shariah Compliance Analysis of Balaxi Pharmaceuticals Ltd
When navigating the Indian stock market, ethical investors constantly seek to align their portfolios with Islamic finance principles. A frequent question we receive is whether Balaxi Pharmaceuticals Ltd (BALAXI) is Halal and Shariah compliant. To accurately determine the Shariah compliance status of Balaxi Pharmaceuticals Ltd, we must conduct a comprehensive quantitative and qualitative analysis of both its core business operations and its underlying financial health.
Business Sector Screening for BALAXI
The very first and most critical step in Halal stock screening is ensuring that the primary business activities of Balaxi Pharmaceuticals Ltd do not violate Islamic law. Companies heavily involved in prohibited (Haraam) sectors like conventional banking, alcohol, gambling, and adult entertainment are strictly excluded. If Balaxi Pharmaceuticals Ltd derives its core revenue from permissible (Halal) activities, it successfully advances to the financial ratio analysis phase.
Financial Ratio Analysis
Even if a prominent company like Balaxi Pharmaceuticals Ltd operates entirely within a Halal sector, it must still pass strict financial screens to guarantee its corporate practices align with Shariah principles.
- Debt to Total Assets: The interest-bearing debt of Balaxi Pharmaceuticals Ltd must not exceed the universally accepted threshold (typically 30% or 33%).
- Illiquid to Total Assets: Balaxi Pharmaceuticals Ltd must maintain a sufficient percentage of tangible, illiquid assets in its portfolio.
- Impermissible Income: Any incidental non-compliant revenue (like interest) must strictly remain below 5% of total gross revenue.
Dividend Purification for Balaxi Pharmaceuticals Ltd
If Balaxi Pharmaceuticals Ltd (BALAXI) passes both the sector screens and strict financial tests, it is classified as a Halal stock. However, any incidental impermissible income earned by the company must be cleansed. Investors holding BALAXI are required to calculate their dividend purification ratio and donate that exact portion to charity, with no expectation of spiritual reward (Sawab), purifying their Halal earnings.
By utilizing our advanced Halal stock screener platform, you can effortlessly track the live Shariah compliance status of Balaxi Pharmaceuticals Ltd (BALAXI), view historical compliance trends, and access precise dividend purification calculations. Make informed, ethical investment decisions with confidence.
⚠️ Disclaimer & Research Notice: This analysis is for informational and reference purposes only. It is not financial advice, and we are not responsible for any financial losses or damages incurred. Always do your own research (DYOR) and consult with a qualified Shariah advisor or financial planner before making any investment decisions.